BREAKING
Eli Lilly and Company (LLY) to acquire Orna Therapeutics 2 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 2 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 3 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 4 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 6 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 6 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 7 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 7 hours ago Innovation and E-Commerce at the Core of Johnson Outdoors’ 2026 Roadmap 7 hours ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 3 days ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 2 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 2 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 3 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 4 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 6 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 6 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 7 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 7 hours ago Innovation and E-Commerce at the Core of Johnson Outdoors’ 2026 Roadmap 7 hours ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 3 days ago
ADVERTISEMENT
Market News

Key takeaways from Altria’s (MO) Q3 2025 earnings report

Shares of Altria Group, Inc. (NYSE: MO) fell 6% on Thursday after the company released its third quarter 2025 earnings results. Revenues missed expectations while earnings came in line. The company raised its guidance for the full year of 2025. Here are the main takeaways from the report: Revenue decline, earnings growth In Q3 2025, […]

$MO October 30, 2025 2 min read

Shares of Altria Group, Inc. (NYSE: MO) fell 6% on Thursday after the company released its third quarter 2025 earnings results. Revenues missed expectations while earnings came in line. The company raised its guidance for the full year of 2025. Here are the main takeaways from the report:

Revenue decline, earnings growth

In Q3 2025, Altria’s net revenues decreased 3% year-over-year to $6 billion, mainly due to lower revenues in both its segments. Reported earnings per share increased 5.2% to $1.41. Adjusted EPS rose 4% to $1.45.  

Segment revenue declines

In Q3, revenues in the Smokeable Products segment decreased nearly 3% YoY to $5.4 billion, mainly due to lower shipment volume and higher promotional investments, partly offset by higher pricing. Domestic cigarette shipment volume fell 8.2%, mainly due to the growth of disposable e-vapor products and discretionary income pressures on customers. Discretionary income pressures have led to growth in the discount segment, where there appears to be room for expansion in an inflationary environment.

Marlboro’s retail share of the total cigarette category dropped by 1.2 share points to 40.4%. The brand’s share of the premium segment grew by 0.3 share points to 59.6%.

Revenues in the Oral Tobacco Products segment declined nearly 5% to $689 million, driven by lower shipment volume and a higher percentage of on! shipment volume relative to MST versus the prior year, partly offset by higher pricing. Domestic shipment volume fell 9.6% in the quarter.

ADVERTISEMENT

In the US, the nicotine pouch category grew to 55.7% of the oral tobacco category, up 11.1 share points YoY. on!’s share of the nicotine pouch category dropped 4.1 share points to 15.6%.

Raised outlook

Altria raised the lower end of its outlook for full-year 2025 and now expects adjusted EPS of $5.37-5.45, which represents YoY growth of 3.5-5.0%.

ADVERTISEMENT